WuXi Biologics | Briefing, News, Analysis, Research, Data

WuXi Biologics

WuXi Biologics WuXi AppTec is expected to provide world-class integrated biopharmace

WuXi Biologics is a subsidiary of the WuXi AppTec Group with branches in Wuxi, Shanghai and Suzhou. As a platform for innovative companies to realize their dream of developing new drugs, WuXi AppTec is expected to provide world-class integrated biopharmaceutical R&D and manufacturing services to more innovative biotech companies at home and abroad in the future, accelerating the process of bringing innovative biopharmaceuticals to market in China for the benefit of patients.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Feb 27, 2014

HQ location

Shanghai, China

Legal name

Wuxi Biologics (Shanghai) Co., Ltd.

Website

http://www.wuxibiologics.com.cn

info@wuxibiologics.com

Employees

501-1000

All
News
Analysis
Research

Briefing Jun 21, 2022 05:50 PM · Technology | Healthcare | Financials

Sanlian board Shenma power: the company's gross profit margin declined to a certain extent in the first quarter

Briefing Apr 19, 2022 01:35 PM · Technology | Healthcare | Industrials

Tesla unveiled a new giant 360mwh Megapack energy storage project

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Mar 13, 2022 08:49 PM · Financials

Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan

Briefing Feb 16, 2022 07:49 AM · Financials | Technology | Consumer Staples

The Russian court of appeal approved a fine of $26.4 million for meta

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Financials, Technology

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 14, 2022 05:40 PM · Technology | Healthcare | Industrials

Blue lithium core: the application for non-public offering of shares was approved

Briefing Feb 10, 2022 06:00 PM · Technology | Healthcare

Boten increased cdmo capacity construction of API

Briefing Feb 08, 2022 03:30 PM · Healthcare

Yaoming biological was included in the "unverified list" in the United States, and its share price plummeted

Briefing Feb 08, 2022 12:59 PM · Technology | Consumer Discretionary | Healthcare

Vosges shares: the price of products in overseas markets will increase by 3-5% in 2021, and there is still a price increase plan this year

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Feb 08, 2022 10:59 AM · Technology | Consumer Staples | Healthcare

Yaoming biological suspended trading in Hong Kong

Briefing Feb 08, 2022 10:19 AM · Technology | Healthcare | Industrials

Esten: the rumor that "Xinsong robot will be acquired" is not true without direct cooperation with the Winter Olympic Games

Briefing Feb 08, 2022 10:09 AM · Consumer Staples | Communication | Healthcare

Agricultural driverless enterprise "Zhongke motive power" won tens of millions of yuan of a + round financing

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Feb 07, 2022 08:09 AM · Healthcare

The battery plant jointly built by SK innovation and Ford was started in December last year

Briefing Dec 16, 2021 09:39 AM · Consumer Staples | Healthcare | Financials

Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.

Briefing Dec 15, 2021 02:49 PM · Healthcare | Automotive

Wuxi apptec diving limit in the afternoon

Briefing Dec 07, 2021 10:19 AM · Technology | Consumer Staples | Healthcare

Radio and television express: a variety of products and applications have been certified by financial Xinchuang ecological laboratory

EqualOcean Analysis